Search

everythinglearnresearchcommunity

for

Search:↓

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Androgens increase growth factors in skin cells, which may lead to acne.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Hormones and neuropeptides affect hair growth, with androgens having opposite effects on beard and scalp hair.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Insulin resistance and hyperinsulinism are linked to fertility issues and can worsen symptoms of PCOS.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

In 1981, the punch graft technique was the main method for hair transplantation, and medical treatments for baldness were not very effective.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

New treatments for male hypogonadism are effective and should be personalized.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.